Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A

Ravi R. Thiagarajan, Stephen J. Roth, Steven Margossian, Andrew S. Mackie, Ellis J. Neufeld, Peter C. Laussen, Joseph M. Forbess, Elizabeth D. Blume

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Objective: To report the use of extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation in a patient with hemophilia A and dilated cardiomyopathy. Design: Case report. Interventions and results: During ECMO factor VIII concentrate was administered to maintain a factor VIII level close to 50% of normal control both to decrease the risk of bleeding and to allow standard anticoagulation with heparin. The patient developed an inhibitor to exogenous factor VIII during hospitalization, which was successfully managed with a high-dose continuous infusion of factor VIII during ECMO, the transplant operation, and the postoperative period. Conclusions: We report the successful use of ECMO as a bridge to cardiac transplantation in a patient with hemophilia A and low-level factor VIII inhibitors.

Original languageEnglish (US)
Pages (from-to)985-988
Number of pages4
JournalIntensive Care Medicine
Volume29
Issue number6
StatePublished - Jun 1 2003

Fingerprint

Extracorporeal Membrane Oxygenation
Factor VIII
Hemophilia A
Heart Transplantation
Cardiomyopathies
Dilated Cardiomyopathy
Postoperative Period
Heparin
Hospitalization
Hemorrhage
Transplants

Keywords

  • Cardiac transplantation
  • Dilated cardiomyopathy
  • Extracorporeal membrane oxygenation
  • Factor VIII inhibitor
  • Hemophilia A

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Thiagarajan, R. R., Roth, S. J., Margossian, S., Mackie, A. S., Neufeld, E. J., Laussen, P. C., ... Blume, E. D. (2003). Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A. Intensive Care Medicine, 29(6), 985-988.

Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A. / Thiagarajan, Ravi R.; Roth, Stephen J.; Margossian, Steven; Mackie, Andrew S.; Neufeld, Ellis J.; Laussen, Peter C.; Forbess, Joseph M.; Blume, Elizabeth D.

In: Intensive Care Medicine, Vol. 29, No. 6, 01.06.2003, p. 985-988.

Research output: Contribution to journalArticle

Thiagarajan, RR, Roth, SJ, Margossian, S, Mackie, AS, Neufeld, EJ, Laussen, PC, Forbess, JM & Blume, ED 2003, 'Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A', Intensive Care Medicine, vol. 29, no. 6, pp. 985-988.
Thiagarajan RR, Roth SJ, Margossian S, Mackie AS, Neufeld EJ, Laussen PC et al. Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A. Intensive Care Medicine. 2003 Jun 1;29(6):985-988.
Thiagarajan, Ravi R. ; Roth, Stephen J. ; Margossian, Steven ; Mackie, Andrew S. ; Neufeld, Ellis J. ; Laussen, Peter C. ; Forbess, Joseph M. ; Blume, Elizabeth D. / Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A. In: Intensive Care Medicine. 2003 ; Vol. 29, No. 6. pp. 985-988.
@article{4a008f44b8db4f429171cebffae9a1b4,
title = "Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A",
abstract = "Objective: To report the use of extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation in a patient with hemophilia A and dilated cardiomyopathy. Design: Case report. Interventions and results: During ECMO factor VIII concentrate was administered to maintain a factor VIII level close to 50{\%} of normal control both to decrease the risk of bleeding and to allow standard anticoagulation with heparin. The patient developed an inhibitor to exogenous factor VIII during hospitalization, which was successfully managed with a high-dose continuous infusion of factor VIII during ECMO, the transplant operation, and the postoperative period. Conclusions: We report the successful use of ECMO as a bridge to cardiac transplantation in a patient with hemophilia A and low-level factor VIII inhibitors.",
keywords = "Cardiac transplantation, Dilated cardiomyopathy, Extracorporeal membrane oxygenation, Factor VIII inhibitor, Hemophilia A",
author = "Thiagarajan, {Ravi R.} and Roth, {Stephen J.} and Steven Margossian and Mackie, {Andrew S.} and Neufeld, {Ellis J.} and Laussen, {Peter C.} and Forbess, {Joseph M.} and Blume, {Elizabeth D.}",
year = "2003",
month = "6",
day = "1",
language = "English (US)",
volume = "29",
pages = "985--988",
journal = "Intensive Care Medicine",
issn = "0342-4642",
publisher = "Springer Verlag",
number = "6",

}

TY - JOUR

T1 - Extracorporeal membrane oxygenation as a bridge to cardiac transplantation in a patient with cardiomyopathy and hemophilia A

AU - Thiagarajan, Ravi R.

AU - Roth, Stephen J.

AU - Margossian, Steven

AU - Mackie, Andrew S.

AU - Neufeld, Ellis J.

AU - Laussen, Peter C.

AU - Forbess, Joseph M.

AU - Blume, Elizabeth D.

PY - 2003/6/1

Y1 - 2003/6/1

N2 - Objective: To report the use of extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation in a patient with hemophilia A and dilated cardiomyopathy. Design: Case report. Interventions and results: During ECMO factor VIII concentrate was administered to maintain a factor VIII level close to 50% of normal control both to decrease the risk of bleeding and to allow standard anticoagulation with heparin. The patient developed an inhibitor to exogenous factor VIII during hospitalization, which was successfully managed with a high-dose continuous infusion of factor VIII during ECMO, the transplant operation, and the postoperative period. Conclusions: We report the successful use of ECMO as a bridge to cardiac transplantation in a patient with hemophilia A and low-level factor VIII inhibitors.

AB - Objective: To report the use of extracorporeal membrane oxygenation (ECMO) as a bridge to cardiac transplantation in a patient with hemophilia A and dilated cardiomyopathy. Design: Case report. Interventions and results: During ECMO factor VIII concentrate was administered to maintain a factor VIII level close to 50% of normal control both to decrease the risk of bleeding and to allow standard anticoagulation with heparin. The patient developed an inhibitor to exogenous factor VIII during hospitalization, which was successfully managed with a high-dose continuous infusion of factor VIII during ECMO, the transplant operation, and the postoperative period. Conclusions: We report the successful use of ECMO as a bridge to cardiac transplantation in a patient with hemophilia A and low-level factor VIII inhibitors.

KW - Cardiac transplantation

KW - Dilated cardiomyopathy

KW - Extracorporeal membrane oxygenation

KW - Factor VIII inhibitor

KW - Hemophilia A

UR - http://www.scopus.com/inward/record.url?scp=0038804181&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038804181&partnerID=8YFLogxK

M3 - Article

C2 - 12719805

AN - SCOPUS:0038804181

VL - 29

SP - 985

EP - 988

JO - Intensive Care Medicine

JF - Intensive Care Medicine

SN - 0342-4642

IS - 6

ER -